The impact of Myo-inositol supplementation with sleep hygiene education on sleep quality in pregnant wome

Phase 3

Conditions: Sleep quality in pregnancy.
Sleep disorders

Registration Number: IRCT20160208026446N3

Lead Sponsor: Babol University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 60

Inclusion Criteria

Conscious written consent
Pregnant women with singletone pregnancy
Age 18 and over
Gestational age of 14 weeks
Absence of chronic physical diseases such as diabetes, high blood pressure and cardiovascular disease
No history of taking prenatal drugs before pregnancy
No history of sleep disorders before pregnancy
Working women without night shift work
Non-smoking and alcohol
Lack of history of psychiatric use
No history of abortion in previous pregnancies

Exclusion Criteria

Severe depression or severe stress
Death experience of one of the first-degree relatives during pregnancy
Changes in sleep status due to travel

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sleep Quality Score in Pittsburgh Sleep Quality Questionnaire. Timepoint: In the second trimester of pregnancy at weeks 24 to 28 and in the third trimester of pregnancy at weeks 37 to 38 of pregnancy. Method of measurement: Pittsburgh Sleep Quality Index Questionnaire.

Secondary Outcome Measures

Name	Time	Method
eonatal and pregnancy outcomes. Timepoint: The end of pregnancy for the outcome of pregnancy and infancy Method of measurement. Method of measurement: Questionnaire and complete the checklist using file.;Side effect of drug. Timepoint: In the second trimester of pregnancy (week 24-28) and the third trimester of pregnancy (week 37_38). Method of measurement: Drug side effect checklist.